| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/14/2007 | CN1927267A Medicament for animals with heat clearing and dampness eliminating, blood cooling, pathogenic fire purging and detoxifying functions and preparing method thereof |
| 03/14/2007 | CN1927254A Medicament for animals with heat clearing and detoxicating, blood cooling and hemostatic functions and preparing method thereof |
| 03/14/2007 | CN1927251A Medicament for animals with heat clearing and detoxicating functions and preparing method thereof |
| 03/14/2007 | CN1927243A Application of marsilea and water extraction in preparation of medicine for relieving alcoholism and hepatoprotection |
| 03/14/2007 | CN1927234A Chinese medicine toothpaste for treating toothache |
| 03/14/2007 | CN1927233A Chinese medicine preparation for treating toothache and preparation method thereof |
| 03/14/2007 | CN1927232A Process for preparing ganoderma lucidum spore powder and capsule thereof |
| 03/14/2007 | CN1927220A Montmorillonite gelling preparation for treating diarrhea and gastritis and its preparation process |
| 03/14/2007 | CN1927217A Lightweight shale gelite powder for treating gastrointestinal diseases |
| 03/14/2007 | CN1927208A Preparing technique for stomatocace film |
| 03/14/2007 | CN1927198A Tiopronin freeze-dried powder injection with no need of special dissolvant |
| 03/14/2007 | CN1927197A Medical use of 1beta-keto-5, 11(13)-diene eudesmane-12-acid for inhibiting hepatitis B virus |
| 03/14/2007 | CN1927185A Maleic acid trimebutine slow release tablet comprising quick release part and preparing method thereof |
| 03/14/2007 | CN1927050A DHA microcapsule food additives, DHA soft capsule health product and uses thereof |
| 03/14/2007 | CN1304548C Health care wine containing dihydro-myricetin and myricetin composition |
| 03/14/2007 | CN1304416C Heterocyclic tripeptides as hepatitis C inhibitors |
| 03/14/2007 | CN1304382C New p2X* receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases |
| 03/14/2007 | CN1304379C Water-soluble phenylpyridazine compounds and compositions containing the same |
| 03/14/2007 | CN1304377C Metalloproteinase inhibitors |
| 03/14/2007 | CN1304375C Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions |
| 03/14/2007 | CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 03/14/2007 | CN1304029C Medicine for treating toothache and preparation method thereof |
| 03/14/2007 | CN1304021C Medicinal composition and its preparing method |
| 03/14/2007 | CN1304019C Compound artemisia rupestris capsule |
| 03/14/2007 | CN1304009C Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 03/14/2007 | CN1304003C Colon positioning and adhering preparation and its preparing process |
| 03/14/2007 | CN1304000C Use of valsartan in preparing drug for treating lung cancer |
| 03/14/2007 | CN1303998C Pharmaceutical formulations containing darifenacin |
| 03/14/2007 | CN1303993C Soft capsule preparation |
| 03/14/2007 | CN1303992C Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders |
| 03/14/2007 | CN1303976C Maple knotweed mixture for intestine and stomach hualth and its manufacturing method |
| 03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |
| 03/13/2007 | US7189852 Preparing renzapride (hydrochloride) on a laboratory or industrial scale by a simplified process of forming the acyl chloride derivative of 2-(methoxy),3-acyamino,5-chlorobenzoic acid by reacting oxalyl or thionyl chloride in a solvent, e.g. dimethylformamide; coupling with 1-diazabicylo(3.3.1)nonane |
| 03/13/2007 | US7189837 Cell surface molecule-induced macrophage activation |
| 03/13/2007 | US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases |
| 03/13/2007 | US7189761 Nitric oxide donor composition and method for treatment of anal disorders |
| 03/13/2007 | US7189758 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 03/13/2007 | US7189756 Pyrrolidine derivatives |
| 03/13/2007 | US7189751 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 03/13/2007 | US7189744 Crystals of benzimidazole compounds |
| 03/13/2007 | US7189742 For therapy of disorder associated with elevated levels of 5-HT (5-hydroxytryptamine; serotonin) resultant from newly synthesised 5-HT, anxiety, depression, migraine and sleep apnoea |
| 03/13/2007 | US7189739 Antiinflammatory agents; cardiovascular disorders; rheumatic disorders |
| 03/13/2007 | US7189736 Prodrugs of imidazopyridine derivatives |
| 03/13/2007 | US7189719 Sodium channel blockers |
| 03/13/2007 | US7189717 Medicinal compositions promoting bowel movement |
| 03/13/2007 | US7189713 Piperidine derivatives |
| 03/13/2007 | US7189711 Muscle relaxants; central nervous system disorders; Parkinson's disease; Alzheimer's disease; strokes |
| 03/13/2007 | US7189696 Peptide antagonists of zonulin and methods for use of the same |
| 03/13/2007 | US7189525 Human enzymes of the metalloprotease family |
| 03/13/2007 | US7189390 Probiotics for pet food applications |
| 03/13/2007 | US7189389 Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes |
| 03/13/2007 | US7189351 D-tagatose as an anti-biofilm agent |
| 03/13/2007 | CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 03/13/2007 | CA2387533C Purine derivatives |
| 03/13/2007 | CA2373128C Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
| 03/13/2007 | CA2315227C Arylpiperazines having activity at the serotonin 1a receptor |
| 03/08/2007 | WO2007027733A2 Reverse link soft handoff in a wireless multiple-access communication system |
| 03/08/2007 | WO2007027675A1 Therapy for the treatment of disease |
| 03/08/2007 | WO2007026966A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | WO2007026916A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
| 03/08/2007 | WO2007026836A1 Novel therapeutic agent derived from marine organism |
| 03/08/2007 | WO2007026771A1 Injection for intravenous drip |
| 03/08/2007 | WO2007026755A1 Tablet for removal of tongue coating |
| 03/08/2007 | WO2007026742A1 Colonic delivery-type therapeutic agent for inflammatory bowel disease |
| 03/08/2007 | WO2007026474A1 Nutrient composition |
| 03/08/2007 | WO2007026218A2 Chromane substituted 2-alkyl imidazopyridine derivatives and use thereof as acid pump antagonists |
| 03/08/2007 | WO2007025977A2 Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis |
| 03/08/2007 | WO2007025925A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | WO2007009395A8 Schisandrin b preparation |
| 03/08/2007 | WO2006135915A3 Methods and compositions for treating degenerative bone disorders |
| 03/08/2007 | WO2006134492A3 Acarbose methods and formulations for treating chronic constipation |
| 03/08/2007 | WO2006120575A3 Tcr-independent activation of t cells with co-lignation of cd28 and cd81 |
| 03/08/2007 | WO2006111624A3 Anti-inflammatory and/or analgesic composition for the intestine comprising branched maltodextrins |
| 03/08/2007 | WO2006099445A3 Nanocells for diagnosis and treatment of diseases and disorders |
| 03/08/2007 | WO2006027579A3 The treatment of inflammatory disorders and pain |
| 03/08/2007 | WO2003047611A8 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 03/08/2007 | WO2003020702A3 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain |
| 03/08/2007 | US20070054950 3-Azabicyclo[3.1.0]hexane derivatives |
| 03/08/2007 | US20070054913 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
| 03/08/2007 | US20070054902 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists |
| 03/08/2007 | US20070054888 Novel substituted diamine derivatives useful as motilin agonists |
| 03/08/2007 | US20070054881 Anxiolytic agents with reduced sedative and ataxic effects |
| 03/08/2007 | US20070054876 Pharmaceutical composition promoting defecation |
| 03/08/2007 | US20070054861 Therapeutic uses of SMR1 peptides |
| 03/08/2007 | US20070054850 Screening method |
| 03/08/2007 | US20070054312 Human transmembrane proteins |
| 03/08/2007 | US20070053917 Composition and method for the treatment and prevention of enteric bacterial infections |
| 03/08/2007 | US20070053884 Novel adult tissue-derived stem cell and use thereof |
| 03/08/2007 | US20070053849 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 03/08/2007 | DE202006019784U1 Tee-Mischung Tea Mix |
| 03/08/2007 | DE102005041613A1 Use of octahydro-indolo-quinoline compound in the preparation of pharmaceutical composition for the treatment and prophylaxis of gastrointestinal and endocardial disease and carcinoid syndrome |
| 03/08/2007 | CA2621182A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
| 03/08/2007 | CA2620742A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | CA2620469A1 Methods of modulating intestinal fluid balance |
| 03/08/2007 | CA2620034A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 03/08/2007 | CA2619748A1 Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis |
| 03/08/2007 | CA2619565A1 Therapy for the treatment of disease |
| 03/08/2007 | CA2616473A1 4-aryloxy quinoline derivatives as 5-ht6 modulators |
| 03/07/2007 | EP1760079A1 Compounds as cor5 antagonists |